BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liva SG, Tseng YC, Dauki AM, Sovic MG, Vu T, Henderson SE, Kuo YC, Benedict JA, Zhang X, Remaily BC, Kulp SK, Campbell M, Bekaii-Saab T, Phelps MA, Chen CS, Coss CC. Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. EMBO Mol Med 2020;12:e9910. [PMID: 31930715 DOI: 10.15252/emmm.201809910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Peng S, Chen Y, Li T, Mao J, Yang P, Zou B, Luo L, Zhang W, Wang W, Xie R, Li J, Zeng L. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis. Cancer Sci 2022. [PMID: 36083239 DOI: 10.1111/cas.15571] [Reference Citation Analysis]
2 Yi D, Yilihamu Y, Jiang C, Wang R, Lu X, Sang J, Su L. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer. Tissue and Cell 2022;77:101869. [DOI: 10.1016/j.tice.2022.101869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jengelley DHA, Zimmers TA. The Role of Interleukin-6/GP130 Cytokines in Cancer Cachexia. The Systemic Effects of Advanced Cancer 2022. [DOI: 10.1007/978-3-031-09518-4_6] [Reference Citation Analysis]
4 Miyazaki M. Physical Exercise and Skeletal Muscle Adaptation in Cancer Cachexia. Physical Therapy and Research in Patients with Cancer 2022. [DOI: 10.1007/978-981-19-6710-8_11] [Reference Citation Analysis]
5 Chen YM, Lai CH, Lin CY, Tsai YH, Chang YC, Chen HC, Tseng CC, Chang HC, Huang KT, Chen YC, Fang WF, Wang CC, Chao TY, Lin MC. Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation. Nutrients 2021;13:3761. [PMID: 34836017 DOI: 10.3390/nu13113761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Castillo AMM, Vu TT, Liva SG, Chen M, Xie Z, Thomas J, Remaily B, Guo Y, Subrayan UL, Costa T, Helms TH, Irby DJ, Kim K, Owen DH, Kulp SK, Mace TA, Phelps MA, Coss CC. Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans. JCSM Rapid Commun 2021;4:232-44. [PMID: 34514376 DOI: 10.1002/rco2.32] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Collier KA, Valencia H, Newton H, Hade EM, Sborov DW, Cavaliere R, Poi M, Phelps MA, Liva SG, Coss CC, Wang J, Khountham S, Monk P, Shapiro CL, Piekarz R, Hofmeister CC, Welling DB, Mortazavi A. A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer Chemother Pharmacol 2021;87:599-611. [PMID: 33492438 DOI: 10.1007/s00280-020-04229-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Halle JL, Counts BR, Carson JA. Exercise as a therapy for cancer-induced muscle wasting. Sports Medicine and Health Science 2020;2:186-94. [DOI: 10.1016/j.smhs.2020.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Aquila G, Re Cecconi AD, Brault JJ, Corli O, Piccirillo R. Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia. Cells 2020;9:E2536. [PMID: 33255345 DOI: 10.3390/cells9122536] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Schlegel P. A new trend in use of performance enhancing drugs in CrossFit®. Telesna kultura 2020;43:41-50. [DOI: 10.5507/tk.2020.010] [Reference Citation Analysis]
11 Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta Rev Cancer 2020;1873:188359. [PMID: 32222610 DOI: 10.1016/j.bbcan.2020.188359] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]